In-silico screening of cancer associated mutation on PLK1 protein and its structural consequences

被引:0
|
作者
Balu Kamaraj
Vidya Rajendran
Rao Sethumadhavan
Rituraj Purohit
机构
[1] Vellore Institute of Technology University,School of Bio Sciences and Technology (SBST), Bioinformatics Division
[2] Human Genetics Foundation,undefined
[3] Torino,undefined
来源
Journal of Molecular Modeling | 2013年 / 19卷
关键词
Flexibility; Molecular dynamics simulations; PLK-1 protein;
D O I
暂无
中图分类号
学科分类号
摘要
The Polo-like kinases (Plks) are a conserved subfamily of serine-threonine protein kinases that have significant roles in cell proliferation. The serine/threonine protein kinases or polo-like kinase 1 (PLK1) exist in centrosome during interphase and is an important regulatory enzyme in cell cycle progression during M phase. Mutations in mammalian PLK1 were found to be over expressed in various human cancers and it is disrupting the binding ability of polo box domain with target peptide. In this analysis we implemented a computational approach to filter the most deleterious and cancer associated mutation on PLK1 protein. We found W414F as the most deleterious and cancer associated by Polyphen 2.0, SIFT, I-mutant 3.0, PANTHER, PhD-SNP, SNP&GO, Mutpred and Dr Cancer tools. Molecular docking and molecular dynamics simulation (MDS) approach was used to investigate the structural and functional behavior of PLK1 protein upon mutation. MDS and docking results showed stability loss in mutant PLK1 protein. Due to mutation, PLK1 protein became more flexible and alters the dynamic property of protein which might affect the interaction with target peptide and leads to cell proliferation. Our study provided a well designed computational methodology to examine the cancer associated nsSNPs and their molecular mechanism. It further helps scientists to develop a drug therapy against PLK1 cancer-associated diseases.
引用
收藏
页码:5587 / 5599
页数:12
相关论文
共 50 条
  • [41] Cathepsin E, Maspin, PLK1, and Survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancer
    Fristrup, Niels
    Ulhoi, Benedicte Parm
    Birkenkamp-Demtroder, Karin
    Mansilla, Francisco
    Sanchez-Carbayo, Marta
    Segersten, Ulrika
    Malmstrom, Per-Uno
    Hartmann, Arndt
    Palou, Joan
    Alvarez-Mugica, Miguel
    Zieger, Karsten
    Borre, Michael
    Orntoft, Torben F.
    Dyrskjot, Lars
    CANCER RESEARCH, 2012, 72
  • [42] Sensitivity of Cancer Cells to Plk1 Inhibitor GSK461364A Is Associated with Loss of p53 Function and Chromosome Instability
    Degenhardt, Yan
    Greshock, Joel
    Laquerre, Sylvie
    Gilmartin, Aidan G.
    Jing, Junping
    Richter, Mark
    Zhang, Xiping
    Bleam, Maureen
    Halsey, Wendy
    Hughes, Ashley
    Moy, Christopher
    Liu-Sullivan, Nancy
    Powers, Scott
    Bachman, Kurtis
    Jackson, Jeffrey
    Weber, Barbara
    Wooster, Richard
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (07) : 2079 - 2089
  • [43] Structural, functional, molecular docking analysis of a hypothetical protein from Talaromyces marneffei and its molecular dynamic simulation: an in-silico approach
    Munna, Md. Masudur Rahman
    Islam, Md Ariful
    Shanta, Saima Sajnin
    Monty, Masuma Akter
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024,
  • [44] Polo-like kinase 1 (PLK1) and protein kinase IKKε, two markers of cancer, down-regulate IFN induction by MAVS
    Vitour, Damien
    Dabo, Stephanie
    Pour, Malek Ahmadi
    Vilasco, Myriam
    Vidalain, Pierre-Olivier
    Jacob, Yves
    Pineau, Pascal
    Tangy, Frederic
    Hiscott, John
    Meurs, Eliane F.
    CYTOKINE, 2008, 43 (03) : 312 - 312
  • [45] Structural consequences of a cancer-causing BRCA1-BRCT missense mutation
    Williams, RS
    Glover, JNM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (04) : 2630 - 2635
  • [46] Evaluation of Nonsynonymous Single Nucleotide Polymorphisms in the DNMT1 Gene Associated With Gastric Cancer by an In-Silico Approach
    Lakshmi, Valasala Harika
    Swamy, Narayana A.
    Kamma, Sreenivasulu
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2015, 6 (04): : 1519 - 1530
  • [47] Structural investigation of tetrahydropteridin analogues as selective PLK1 inhibitors for treating cancer through combined QSAR techniques, molecular docking, and molecular dynamics simulations
    Tong, Jian-Bo
    Luo, Ding
    Bian, Shuai
    Zhang, Xing
    JOURNAL OF MOLECULAR LIQUIDS, 2021, 335
  • [48] In Silico Analysis of the Structural and Functional Consequences of Polymorphic Amino Acid Substitutions in the Cattle HSF1 Protein
    Atalay, Sertac
    KAFKAS UNIVERSITESI VETERINER FAKULTESI DERGISI, 2022, 28 (03) : 391 - 399
  • [49] In-silico investigations into natural products as non-nucleoside DNA methyltransferase 1 inhibitors for treating epi-mutation in gastric cancer
    Li, Dong-fang
    Wang, Rui-xiao
    Yan, Yong-xia
    Jin, Guo-liang
    Song, Guo-hui
    Ma, Deng-bin
    Guan, Li
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (02) : 445 - 451
  • [50] PLK1, polo-like kinase 1, is significantly associated with worse prognosis resulting from activated cell cycle and DNA repair deficiency in breast cancer
    Takeshita, Takashi
    Asakawa, Mariko
    Katsuta, Eriko
    Okano, Maiko
    Oshi, Masanori
    Takabe, Kazuaki
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : 178 - 178